- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
Augmented Reality Platform To Be Presented At 2023 Wells Fargo Healthcare Conference
OnPoint, a group of privately held AR companies, will present the platform.
A group of privately held AR companies announced that it will be presenting its augmented reality (AR) platform at the 2023 Wells Fargo Healthcare Conference on September 6, 2023, in Boston.
OnPoint is focused on creating new AR-based technologies for use with spinal, neurosurgical, and orthopedic surgical procedures. At the event in Boston, the group will present the OnPoint Alm-AR technology platform.
In a press release, OnPoint’s CEO and chairman Philipp Lang said, “OnPoint offers an attractive financial profile for hospitals and ASC's using its rapidly accretive, exceptionally accurate and cost-effective technology. It is a modular platform technology programmed for brisk expansion, since it is at the nexus of free-hand and robotic surgery. The technology is backed by an equally impressive IP portfolio of granted U.S. and international patents with a value exceeding $200 million.”
The platform is designed to be used with wearable headsets that use a transparent optical display to present surgical guides and other information to surgeons during procedures.
Trial Launches to Explore Using Virtual Reality to Treat Shortsightedness in Children
July 27th 2023A new trial will determine the effectiveness of using virtual reality to treat myopia in children. The treatment combines the use of a VR headset with a phone app that is designed to stimulate dopamine releases in the retina.
